Literature DB >> 3006113

Effects of antidepressant drugs, selective noradrenaline-or 5-hydroxytryptamine uptake inhibitors, on apomorphine-induced hypothermia in mice.

L Pawłowski, H Mazela.   

Abstract

Antidepressant drugs which are selective noradrenaline (NA) uptake inhibitors (desipramine, maprotiline, oxaprotiline, talsupram: 0.625-10 mg/kg) antagonized dose-dependently hypothermia induced by 16 mg/kg apomorphine (APO) in mice. Of the two stereoisomers of oxaprotiline, only that inhibiting NA uptake was active. Antidepressants which are selective 5-hydroxytryptamine (5-HT) uptake inhibitors (citalopram, fluvoxamine: 2.5-40 mg/kg) did not affect APO (16 mg/kg)-induced hypothermia. Neither NA nor 5-HT uptake inhibitors counteracted hypothermia induced by 1 mg/kg APO, a dose which is easily antagonized by low doses of dopamine receptor blockers. The antagonistic action of desipramine towards APO (16 mg/kg)-induced hypothermia was prevented by phenoxybenzamine, prazosin and (-)-propranolol, while (+)-propranolol and cyproheptadine were inactive. St. 587 (an alpha 1-adrenoceptor agonist) or salbutamol (an agonist of beta-adrenoceptors) attenuated APO (16 mg/kg)-induced hypothermia: given jointly, the drugs completely reversed it. m-CPP, a 5-HT receptor agonist, did not affect APO (16 mg/kg)-induced hypothermia. In conclusion, the antagonistic action of antidepressant drugs towards APO (16 mg/kg)-induced hypothermia in mice did not reflect their "antidepressant properties", dopamine antagonism or their action on 5-HT receptors, only their effects on the NA uptake and/or NA transmission. Both alpha 1 and beta-adrenoceptors are involved in this antagonistic action.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006113     DOI: 10.1007/bf00652248

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Apomorphine: chemistry, pharmacology, biochemistry.

Authors:  F C Colpaert; W F Van Bever; J E Leysen
Journal:  Int Rev Neurobiol       Date:  1976       Impact factor: 3.230

2.  Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant.

Authors:  P Simon; Y Lecrubier; R Jouvent; A J Puech; J F Allilaire; D Widlöcher
Journal:  Psychol Med       Date:  1978-05       Impact factor: 7.723

Review 3.  Pharmacology and neurochemistry of apomorphine.

Authors:  G Di Chiara; G L Gessa
Journal:  Adv Pharmacol Chemother       Date:  1978

4.  Hypothermic effect of apomorphine in the mouse.

Authors:  K Fuxe; F Sjöqvist
Journal:  J Pharm Pharmacol       Date:  1972-09       Impact factor: 3.765

5.  The effect of tricyclic antidepressants on apomorphine-induced hypothermia in the mouse.

Authors:  J Maj; L Pawlowski; G Wiszniowska
Journal:  Pol J Pharmacol Pharm       Date:  1974 May-Jun

6.  Apomorphine-induced hypothermia in mice; a possible dopaminergic effect.

Authors:  A Barnett; J Goldstein; R I Taber
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-08

7.  5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.

Authors:  A Rokosz-Pelc; L Antkiewicz-Michaluk; J Vetulani
Journal:  J Pharm Pharmacol       Date:  1980-03       Impact factor: 3.765

8.  A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study.

Authors:  Y Lecrubier; A J Puech; R Jouvent; P Simon; D Widlocher
Journal:  Br J Psychiatry       Date:  1980-04       Impact factor: 9.319

9.  Pharmacological studies on the antagonism by antidepressants of the hypothermia induced by apomorphine.

Authors:  M K Menon; C A Vivonia; A S Kling
Journal:  Neuropharmacology       Date:  1984-02       Impact factor: 5.250

10.  Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats.

Authors:  R Samanin; T Mennini; A Ferraris; C Bendotti; F Borsini; S Garattini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

View more
  3 in total

1.  Some central pharmacological effects of (+)- and (-)-oxaprotiline.

Authors:  J Maj; Z Rogóź; G Skuza; H Sowińska
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 2.  Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.

Authors:  R J Milne; K L Goa
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

3.  Oxaprotiline enantiomers given repeatedly and brain alpha-adrenoceptors.

Authors:  J Maj; K Wedzony; V Klimek; Z Rogóz; G Skuz
Journal:  J Neural Transm Gen Sect       Date:  1990
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.